nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—ovarian cancer	0.455	1	CbGaD
Methylprednisolone—ABCB1—Topotecan—ovarian cancer	0.0752	0.221	CbGbCtD
Methylprednisolone—ABCB1—Vinorelbine—ovarian cancer	0.053	0.156	CbGbCtD
Methylprednisolone—CYP3A4—Topotecan—ovarian cancer	0.045	0.133	CbGbCtD
Methylprednisolone—ABCB1—Paclitaxel—ovarian cancer	0.0372	0.11	CbGbCtD
Methylprednisolone—CYP3A4—Vinorelbine—ovarian cancer	0.0317	0.0935	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—ovarian cancer	0.0269	0.0793	CbGbCtD
Methylprednisolone—CYP3A4—Paclitaxel—ovarian cancer	0.0223	0.0657	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—ovarian cancer	0.0201	0.0591	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—ovarian cancer	0.0161	0.0475	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—ovarian cancer	0.012	0.0354	CbGbCtD
Methylprednisolone—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.000564	0.177	CrCbGaD
Methylprednisolone—Fluticasone Propionate—PGR—ovarian cancer	0.000559	0.176	CrCbGaD
Methylprednisolone—Betamethasone—PGR—ovarian cancer	0.000512	0.161	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.000356	0.112	CrCbGaD
Methylprednisolone—Dexamethasone—PGR—ovarian cancer	0.000298	0.0936	CrCbGaD
Methylprednisolone—Dexamethasone—CYP1B1—ovarian cancer	0.000278	0.0874	CrCbGaD
Methylprednisolone—NR3C1—myometrium—ovarian cancer	0.000255	0.0681	CbGeAlD
Methylprednisolone—NR3C1—embryo—ovarian cancer	0.000246	0.0655	CbGeAlD
Methylprednisolone—Urticaria—Vinorelbine—ovarian cancer	0.000219	0.0011	CcSEcCtD
Methylprednisolone—Abdominal pain—Vinorelbine—ovarian cancer	0.000218	0.0011	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Docetaxel—ovarian cancer	0.000217	0.0011	CcSEcCtD
Methylprednisolone—Diarrhoea—Melphalan—ovarian cancer	0.000216	0.00109	CcSEcCtD
Methylprednisolone—Osteoarthritis—Epirubicin—ovarian cancer	0.000216	0.00109	CcSEcCtD
Methylprednisolone—Nausea—Chlorambucil—ovarian cancer	0.000215	0.00108	CcSEcCtD
Methylprednisolone—Visual impairment—Docetaxel—ovarian cancer	0.000213	0.00107	CcSEcCtD
Methylprednisolone—Dizziness—Topotecan—ovarian cancer	0.000213	0.00107	CcSEcCtD
Methylprednisolone—Increased appetite—Doxorubicin—ovarian cancer	0.000212	0.00107	CcSEcCtD
Methylprednisolone—Affect lability—Epirubicin—ovarian cancer	0.000212	0.00107	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000211	0.00106	CcSEcCtD
Methylprednisolone—Angioedema—Paclitaxel—ovarian cancer	0.000208	0.00105	CcSEcCtD
Methylprednisolone—Eye disorder—Docetaxel—ovarian cancer	0.000207	0.00104	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000206	0.00104	CcSEcCtD
Methylprednisolone—Cardiac disorder—Docetaxel—ovarian cancer	0.000205	0.00103	CcSEcCtD
Methylprednisolone—Cardiac arrest—Epirubicin—ovarian cancer	0.000205	0.00103	CcSEcCtD
Methylprednisolone—Vomiting—Topotecan—ovarian cancer	0.000205	0.00103	CcSEcCtD
Methylprednisolone—Malaise—Paclitaxel—ovarian cancer	0.000205	0.00103	CcSEcCtD
Methylprednisolone—Cardiac failure—Doxorubicin—ovarian cancer	0.000204	0.00103	CcSEcCtD
Methylprednisolone—Mood swings—Epirubicin—ovarian cancer	0.000204	0.00103	CcSEcCtD
Methylprednisolone—Vertigo—Paclitaxel—ovarian cancer	0.000204	0.00103	CcSEcCtD
Methylprednisolone—Syncope—Paclitaxel—ovarian cancer	0.000204	0.00103	CcSEcCtD
Methylprednisolone—Rash—Topotecan—ovarian cancer	0.000203	0.00102	CcSEcCtD
Methylprednisolone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000203	0.00102	CcSEcCtD
Methylprednisolone—Dermatitis—Topotecan—ovarian cancer	0.000203	0.00102	CcSEcCtD
Methylprednisolone—Headache—Topotecan—ovarian cancer	0.000202	0.00102	CcSEcCtD
Methylprednisolone—Angiopathy—Docetaxel—ovarian cancer	0.000201	0.00101	CcSEcCtD
Methylprednisolone—Vomiting—Melphalan—ovarian cancer	0.000201	0.00101	CcSEcCtD
Methylprednisolone—NR3C1—epithelium—ovarian cancer	0.0002	0.0535	CbGeAlD
Methylprednisolone—Immune system disorder—Docetaxel—ovarian cancer	0.0002	0.00101	CcSEcCtD
Methylprednisolone—Loss of consciousness—Paclitaxel—ovarian cancer	0.0002	0.00101	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—ovarian cancer	0.0002	0.00101	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Docetaxel—ovarian cancer	0.000199	0.001	CcSEcCtD
Methylprednisolone—Rash—Melphalan—ovarian cancer	0.000199	0.001	CcSEcCtD
Methylprednisolone—NR3C1—uterine cervix—ovarian cancer	0.000199	0.053	CbGeAlD
Methylprednisolone—Dermatitis—Melphalan—ovarian cancer	0.000199	0.001	CcSEcCtD
Methylprednisolone—Asthenia—Vinorelbine—ovarian cancer	0.000198	0.000996	CcSEcCtD
Methylprednisolone—Arrhythmia—Docetaxel—ovarian cancer	0.000198	0.000996	CcSEcCtD
Methylprednisolone—Convulsion—Paclitaxel—ovarian cancer	0.000197	0.000992	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—ovarian cancer	0.000196	0.00099	CcSEcCtD
Methylprednisolone—Hypertension—Paclitaxel—ovarian cancer	0.000196	0.000988	CcSEcCtD
Methylprednisolone—Pruritus—Vinorelbine—ovarian cancer	0.000195	0.000983	CcSEcCtD
Methylprednisolone—Breast disorder—Epirubicin—ovarian cancer	0.000195	0.000982	CcSEcCtD
Methylprednisolone—Mental disorder—Docetaxel—ovarian cancer	0.000194	0.000976	CcSEcCtD
Methylprednisolone—Myalgia—Paclitaxel—ovarian cancer	0.000193	0.000975	CcSEcCtD
Methylprednisolone—Arthralgia—Paclitaxel—ovarian cancer	0.000193	0.000975	CcSEcCtD
Methylprednisolone—Anxiety—Paclitaxel—ovarian cancer	0.000193	0.000971	CcSEcCtD
Methylprednisolone—Erythema—Docetaxel—ovarian cancer	0.000193	0.00097	CcSEcCtD
Methylprednisolone—Malnutrition—Docetaxel—ovarian cancer	0.000193	0.00097	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000192	0.000968	CcSEcCtD
Methylprednisolone—Nausea—Topotecan—ovarian cancer	0.000191	0.000964	CcSEcCtD
Methylprednisolone—Discomfort—Paclitaxel—ovarian cancer	0.000191	0.000963	CcSEcCtD
Methylprednisolone—Muscular weakness—Epirubicin—ovarian cancer	0.00019	0.000958	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00019	0.000958	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—ovarian cancer	0.00019	0.000956	CcSEcCtD
Methylprednisolone—NR3C1—decidua—ovarian cancer	0.000189	0.0505	CbGeAlD
Methylprednisolone—Mood swings—Doxorubicin—ovarian cancer	0.000189	0.000952	CcSEcCtD
Methylprednisolone—Diarrhoea—Vinorelbine—ovarian cancer	0.000189	0.00095	CcSEcCtD
Methylprednisolone—Abdominal distension—Epirubicin—ovarian cancer	0.000188	0.000945	CcSEcCtD
Methylprednisolone—Nausea—Melphalan—ovarian cancer	0.000187	0.000944	CcSEcCtD
Methylprednisolone—Confusional state—Paclitaxel—ovarian cancer	0.000187	0.000942	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000185	0.000934	CcSEcCtD
Methylprednisolone—Infection—Paclitaxel—ovarian cancer	0.000184	0.000928	CcSEcCtD
Methylprednisolone—Pancreatitis—Epirubicin—ovarian cancer	0.000183	0.000921	CcSEcCtD
Methylprednisolone—Shock—Paclitaxel—ovarian cancer	0.000182	0.000919	CcSEcCtD
Methylprednisolone—Dizziness—Vinorelbine—ovarian cancer	0.000182	0.000918	CcSEcCtD
Methylprednisolone—Nervous system disorder—Paclitaxel—ovarian cancer	0.000182	0.000916	CcSEcCtD
Methylprednisolone—Tachycardia—Paclitaxel—ovarian cancer	0.000181	0.000912	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—ovarian cancer	0.00018	0.000909	CcSEcCtD
Methylprednisolone—Skin disorder—Paclitaxel—ovarian cancer	0.00018	0.000907	CcSEcCtD
Methylprednisolone—NR3C1—endometrium—ovarian cancer	0.00018	0.048	CbGeAlD
Methylprednisolone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000179	0.000903	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—ovarian cancer	0.000176	0.000887	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000176	0.000887	CcSEcCtD
Methylprednisolone—Vomiting—Vinorelbine—ovarian cancer	0.000175	0.000883	CcSEcCtD
Methylprednisolone—Rash—Vinorelbine—ovarian cancer	0.000174	0.000876	CcSEcCtD
Methylprednisolone—Dermatitis—Vinorelbine—ovarian cancer	0.000174	0.000875	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—ovarian cancer	0.000174	0.000875	CcSEcCtD
Methylprednisolone—Hypotension—Paclitaxel—ovarian cancer	0.000173	0.000873	CcSEcCtD
Methylprednisolone—Headache—Vinorelbine—ovarian cancer	0.000173	0.00087	CcSEcCtD
Methylprednisolone—Syncope—Docetaxel—ovarian cancer	0.000173	0.00087	CcSEcCtD
Methylprednisolone—Weight increased—Epirubicin—ovarian cancer	0.00017	0.000855	CcSEcCtD
Methylprednisolone—Loss of consciousness—Docetaxel—ovarian cancer	0.000169	0.000853	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—ovarian cancer	0.000169	0.000852	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000169	0.000851	CcSEcCtD
Methylprednisolone—Insomnia—Paclitaxel—ovarian cancer	0.000168	0.000845	CcSEcCtD
Methylprednisolone—Convulsion—Docetaxel—ovarian cancer	0.000167	0.000841	CcSEcCtD
Methylprednisolone—NR3C1—gonad—ovarian cancer	0.000167	0.0445	CbGeAlD
Methylprednisolone—Paraesthesia—Paclitaxel—ovarian cancer	0.000166	0.000839	CcSEcCtD
Methylprednisolone—Hypertension—Docetaxel—ovarian cancer	0.000166	0.000838	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—ovarian cancer	0.000166	0.000837	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—ovarian cancer	0.000166	0.000837	CcSEcCtD
Methylprednisolone—NR3C1—uterus—ovarian cancer	0.000166	0.0442	CbGeAlD
Methylprednisolone—Arthralgia—Docetaxel—ovarian cancer	0.000164	0.000826	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—ovarian cancer	0.000164	0.000826	CcSEcCtD
Methylprednisolone—Nausea—Vinorelbine—ovarian cancer	0.000164	0.000825	CcSEcCtD
Methylprednisolone—Dyspepsia—Paclitaxel—ovarian cancer	0.000163	0.000822	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000163	0.000821	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000163	0.00082	CcSEcCtD
Methylprednisolone—Fatigue—Paclitaxel—ovarian cancer	0.00016	0.000805	CcSEcCtD
Methylprednisolone—Sweating—Epirubicin—ovarian cancer	0.000159	0.000803	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—ovarian cancer	0.000158	0.000798	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000157	0.000792	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—ovarian cancer	0.000157	0.000791	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—ovarian cancer	0.000156	0.000787	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—ovarian cancer	0.000155	0.000779	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—ovarian cancer	0.000154	0.000777	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—ovarian cancer	0.000154	0.000775	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—ovarian cancer	0.000154	0.000775	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—ovarian cancer	0.000153	0.000773	CcSEcCtD
Methylprednisolone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000153	0.00077	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—ovarian cancer	0.000153	0.000769	CcSEcCtD
Methylprednisolone—Prednisone—ABCB1—ovarian cancer	0.000152	0.0478	CrCbGaD
Methylprednisolone—Bradycardia—Epirubicin—ovarian cancer	0.000152	0.000765	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000152	0.000764	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000151	0.00076	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—ovarian cancer	0.00015	0.000756	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—ovarian cancer	0.00015	0.000754	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—ovarian cancer	0.000149	0.000752	CcSEcCtD
Methylprednisolone—NR3C1—female reproductive system—ovarian cancer	0.000149	0.0397	CbGeAlD
Methylprednisolone—Sweating—Doxorubicin—ovarian cancer	0.000147	0.000743	CcSEcCtD
Methylprednisolone—Urticaria—Paclitaxel—ovarian cancer	0.000147	0.000742	CcSEcCtD
Methylprednisolone—Hypotension—Docetaxel—ovarian cancer	0.000147	0.00074	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000147	0.000739	CcSEcCtD
Methylprednisolone—Abdominal pain—Paclitaxel—ovarian cancer	0.000147	0.000738	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—ovarian cancer	0.000144	0.000724	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000143	0.000721	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—ovarian cancer	0.000142	0.000716	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—ovarian cancer	0.000141	0.000711	CcSEcCtD
Methylprednisolone—NR3C1—bone marrow—ovarian cancer	0.000141	0.0375	CbGeAlD
Methylprednisolone—Bradycardia—Doxorubicin—ovarian cancer	0.000141	0.000708	CcSEcCtD
Methylprednisolone—Prednisolone—ABCB1—ovarian cancer	0.00014	0.044	CrCbGaD
Methylprednisolone—Eye disorder—Epirubicin—ovarian cancer	0.000139	0.000703	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—ovarian cancer	0.000139	0.000699	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—ovarian cancer	0.000138	0.000698	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—ovarian cancer	0.000138	0.000697	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—ovarian cancer	0.000138	0.000697	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—ovarian cancer	0.000138	0.000696	CcSEcCtD
Methylprednisolone—Betamethasone—ABCB1—ovarian cancer	0.000137	0.0431	CrCbGaD
Methylprednisolone—ABCB1—myometrium—ovarian cancer	0.000137	0.0365	CbGeAlD
Methylprednisolone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000137	0.000688	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000136	0.000684	CcSEcCtD
Methylprednisolone—NR3C1—female gonad—ovarian cancer	0.000136	0.0361	CbGeAlD
Methylprednisolone—Fatigue—Docetaxel—ovarian cancer	0.000135	0.000683	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—ovarian cancer	0.000135	0.000682	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—ovarian cancer	0.000135	0.000679	CcSEcCtD
Methylprednisolone—NR3C1—vagina—ovarian cancer	0.000135	0.0359	CbGeAlD
Methylprednisolone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000134	0.000678	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—ovarian cancer	0.000133	0.000672	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—ovarian cancer	0.000133	0.00067	CcSEcCtD
Methylprednisolone—Asthenia—Paclitaxel—ovarian cancer	0.000133	0.00067	CcSEcCtD
Methylprednisolone—ABCB1—embryo—ovarian cancer	0.000132	0.0351	CbGeAlD
Methylprednisolone—Pruritus—Paclitaxel—ovarian cancer	0.000131	0.000661	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—ovarian cancer	0.000131	0.000659	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—ovarian cancer	0.00013	0.000654	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—ovarian cancer	0.00013	0.000654	CcSEcCtD
Methylprednisolone—Feeling abnormal—Docetaxel—ovarian cancer	0.000129	0.000653	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—ovarian cancer	0.000129	0.00065	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000128	0.000647	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000128	0.000646	CcSEcCtD
Methylprednisolone—Diarrhoea—Paclitaxel—ovarian cancer	0.000127	0.000639	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—ovarian cancer	0.000125	0.000631	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—ovarian cancer	0.000125	0.000628	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000124	0.000627	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—ovarian cancer	0.000124	0.000626	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—ovarian cancer	0.000123	0.000621	CcSEcCtD
Methylprednisolone—Dizziness—Paclitaxel—ovarian cancer	0.000123	0.000618	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—ovarian cancer	0.000121	0.000609	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—ovarian cancer	0.00012	0.000607	CcSEcCtD
Methylprednisolone—NR3C1—testis—ovarian cancer	0.00012	0.0321	CbGeAlD
Methylprednisolone—Erythema—Doxorubicin—ovarian cancer	0.00012	0.000606	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—ovarian cancer	0.00012	0.000606	CcSEcCtD
Methylprednisolone—Vomiting—Paclitaxel—ovarian cancer	0.000118	0.000594	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—ovarian cancer	0.000117	0.00059	CcSEcCtD
Methylprednisolone—Rash—Paclitaxel—ovarian cancer	0.000117	0.000589	CcSEcCtD
Methylprednisolone—Dermatitis—Paclitaxel—ovarian cancer	0.000117	0.000588	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—ovarian cancer	0.000117	0.000588	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—ovarian cancer	0.000116	0.000587	CcSEcCtD
Methylprednisolone—Headache—Paclitaxel—ovarian cancer	0.000116	0.000585	CcSEcCtD
Methylprednisolone—Hypersensitivity—Docetaxel—ovarian cancer	0.000116	0.000583	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—ovarian cancer	0.000114	0.000575	CcSEcCtD
Methylprednisolone—Asthenia—Docetaxel—ovarian cancer	0.000113	0.000568	CcSEcCtD
Methylprednisolone—CYP3A4—female reproductive system—ovarian cancer	0.000113	0.03	CbGeAlD
Methylprednisolone—Convulsion—Epirubicin—ovarian cancer	0.000113	0.000567	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—ovarian cancer	0.000112	0.000565	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000111	0.000562	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—ovarian cancer	0.000111	0.00056	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—ovarian cancer	0.000111	0.000557	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—ovarian cancer	0.000111	0.000557	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—ovarian cancer	0.00011	0.000555	CcSEcCtD
Methylprednisolone—Nausea—Paclitaxel—ovarian cancer	0.00011	0.000555	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00011	0.000553	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—ovarian cancer	0.000109	0.00055	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—ovarian cancer	0.000108	0.000546	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—ovarian cancer	0.000108	0.000544	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—ovarian cancer	0.000108	0.000543	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—ovarian cancer	0.000107	0.000542	CcSEcCtD
Methylprednisolone—ABCB1—epithelium—ovarian cancer	0.000107	0.0286	CbGeAlD
Methylprednisolone—Hydrocortisone—ABCB1—ovarian cancer	0.000107	0.0337	CrCbGaD
Methylprednisolone—Confusional state—Epirubicin—ovarian cancer	0.000107	0.000539	CcSEcCtD
Methylprednisolone—ABCB1—uterine cervix—ovarian cancer	0.000106	0.0284	CbGeAlD
Methylprednisolone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000106	0.000534	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—ovarian cancer	0.000106	0.000532	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—ovarian cancer	0.000105	0.000531	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—ovarian cancer	0.000104	0.000525	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—ovarian cancer	0.000104	0.000525	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—ovarian cancer	0.000104	0.000524	CcSEcCtD
Methylprednisolone—Dizziness—Docetaxel—ovarian cancer	0.000104	0.000524	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—ovarian cancer	0.000104	0.000523	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—ovarian cancer	0.000103	0.000521	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—ovarian cancer	0.000103	0.000519	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000102	0.000516	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—ovarian cancer	0.000102	0.000515	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—ovarian cancer	0.000102	0.000515	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—ovarian cancer	0.000102	0.000514	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000102	0.000512	CcSEcCtD
Methylprednisolone—ABCB1—decidua—ovarian cancer	0.000101	0.027	CbGeAlD
Methylprednisolone—Discomfort—Doxorubicin—ovarian cancer	0.000101	0.000509	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—ovarian cancer	9.99e-05	0.000503	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—ovarian cancer	9.91e-05	0.000499	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—ovarian cancer	9.9e-05	0.000499	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—ovarian cancer	9.9e-05	0.000499	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—ovarian cancer	9.89e-05	0.000498	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—ovarian cancer	9.84e-05	0.000496	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—ovarian cancer	9.81e-05	0.000494	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—ovarian cancer	9.74e-05	0.000491	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.66e-05	0.000487	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—ovarian cancer	9.65e-05	0.000486	CcSEcCtD
Methylprednisolone—ABCB1—endometrium—ovarian cancer	9.62e-05	0.0257	CbGeAlD
Methylprednisolone—Nervous system disorder—Doxorubicin—ovarian cancer	9.62e-05	0.000485	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—ovarian cancer	9.58e-05	0.000483	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—ovarian cancer	9.57e-05	0.000482	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—ovarian cancer	9.52e-05	0.00048	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—ovarian cancer	9.52e-05	0.00048	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—ovarian cancer	9.48e-05	0.000478	CcSEcCtD
Methylprednisolone—Nausea—Docetaxel—ovarian cancer	9.33e-05	0.00047	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—ovarian cancer	9.33e-05	0.00047	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—ovarian cancer	9.16e-05	0.000462	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—ovarian cancer	9.14e-05	0.00046	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.93e-05	0.00045	CcSEcCtD
Methylprednisolone—ABCB1—gonad—ovarian cancer	8.93e-05	0.0238	CbGeAlD
Methylprednisolone—Insomnia—Doxorubicin—ovarian cancer	8.87e-05	0.000447	CcSEcCtD
Methylprednisolone—ABCB1—uterus—ovarian cancer	8.87e-05	0.0237	CbGeAlD
Methylprednisolone—Paraesthesia—Doxorubicin—ovarian cancer	8.8e-05	0.000444	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—ovarian cancer	8.73e-05	0.00044	CcSEcCtD
Methylprednisolone—NR3C1—lymph node—ovarian cancer	8.71e-05	0.0232	CbGeAlD
Methylprednisolone—Gastrointestinal pain—Epirubicin—ovarian cancer	8.67e-05	0.000437	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—ovarian cancer	8.63e-05	0.000435	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—ovarian cancer	8.45e-05	0.000426	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—ovarian cancer	8.42e-05	0.000424	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—ovarian cancer	8.38e-05	0.000422	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—ovarian cancer	8.08e-05	0.000407	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.02e-05	0.000404	CcSEcCtD
Methylprednisolone—Dexamethasone—ABCB1—ovarian cancer	7.99e-05	0.0251	CrCbGaD
Methylprednisolone—ABCB1—female reproductive system—ovarian cancer	7.97e-05	0.0213	CbGeAlD
Methylprednisolone—Hypersensitivity—Epirubicin—ovarian cancer	7.81e-05	0.000393	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—ovarian cancer	7.79e-05	0.000393	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—ovarian cancer	7.75e-05	0.000391	CcSEcCtD
Methylprednisolone—Asthenia—Epirubicin—ovarian cancer	7.6e-05	0.000383	CcSEcCtD
Methylprednisolone—ABCB1—bone marrow—ovarian cancer	7.53e-05	0.0201	CbGeAlD
Methylprednisolone—Pruritus—Epirubicin—ovarian cancer	7.5e-05	0.000378	CcSEcCtD
Methylprednisolone—ABCB1—female gonad—ovarian cancer	7.25e-05	0.0194	CbGeAlD
Methylprednisolone—Diarrhoea—Epirubicin—ovarian cancer	7.25e-05	0.000365	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—ovarian cancer	7.22e-05	0.000364	CcSEcCtD
Methylprednisolone—ABCB1—vagina—ovarian cancer	7.21e-05	0.0192	CbGeAlD
Methylprednisolone—Asthenia—Doxorubicin—ovarian cancer	7.04e-05	0.000355	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—ovarian cancer	7.01e-05	0.000353	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—ovarian cancer	6.94e-05	0.00035	CcSEcCtD
Methylprednisolone—Vomiting—Epirubicin—ovarian cancer	6.74e-05	0.00034	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—ovarian cancer	6.71e-05	0.000338	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—ovarian cancer	6.68e-05	0.000337	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—ovarian cancer	6.68e-05	0.000336	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—ovarian cancer	6.64e-05	0.000335	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—ovarian cancer	6.48e-05	0.000327	CcSEcCtD
Methylprednisolone—ABCB1—testis—ovarian cancer	6.43e-05	0.0172	CbGeAlD
Methylprednisolone—Nausea—Epirubicin—ovarian cancer	6.29e-05	0.000317	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—ovarian cancer	6.23e-05	0.000314	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—ovarian cancer	6.18e-05	0.000312	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—ovarian cancer	6.18e-05	0.000311	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—ovarian cancer	6.14e-05	0.00031	CcSEcCtD
Methylprednisolone—Nausea—Doxorubicin—ovarian cancer	5.82e-05	0.000294	CcSEcCtD
Methylprednisolone—ABCB1—lymph node—ovarian cancer	4.66e-05	0.0124	CbGeAlD
